Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody. [electronic resource]
- American journal of clinical oncology Aug 2003
- 408-10 p. digital
Publication Type: Case Reports; Journal Article
1537-453X
10.1097/01.COC.0000026485.57632.1E doi
Adult Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Murine-Derived Antigens, CD20 Antineoplastic Agents--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Duodenal Neoplasms--drug therapy Female Humans Lymphoma, Non-Hodgkin--drug therapy Rituximab Treatment Failure